Currently holds positions in Thermo Fisher Scientific Inc and Editas Medicine Inc
Position | Company | Period |
---|---|---|
Director | Thermo Fisher Scientific Inc | Nov. 8, 2018 - |
Independent Chairman of the Board | Editas Medicine Inc | March 27, 2018 - |
Independent Director | Insulet Corp | Aug. 9, 2017 - Jan. 25, 2019 |
Independent Director | PerkinElmer Inc | Jan. 1, 2004 - April 28, 2015 |
Search
Notification date | Transaction date | B/S Transaction type |
Nb. shares Price Value |
Number of shares | Price | Total value | Details | |
---|---|---|---|---|---|---|---|---|
2022-01-04 | 2022-01-03 |
Editas Medicine Inc
(EDIT)
|
S Sale |
18,252
-19.4%
26.95491,979 USD |
18,252 -19.4% | 26.95 | 491,979 USD | |
2021-10-20 | 2021-10-18 |
Editas Medicine Inc
(EDIT)
|
S Sale |
13,805
-19.3%
38.03525,033 USD |
13,805 -19.3% | 38.03 | 525,033 USD | |
2021-03-04 | 2021-03-02 |
Editas Medicine Inc
(EDIT)
|
B Purchase |
25,000
+250.0%
46.271,156,800 USD |
25,000 +250.0% | 46.27 | 1,156,800 USD | |
2004-10-20 | 2004-10-18 |
Biogen Inc
(BIIB)
|
PS Planned sale |
1,500
-3.8%
57.8186,711 USD |
1,500 -3.8% | 57.81 | 86,711 USD | |
2004-10-20 | 2004-10-18 |
Biogen Inc
(BIIB)
|
PS Planned sale |
1,500
-3.7%
58.0587,073 USD |
1,500 -3.7% | 58.05 | 87,073 USD | |
2004-10-20 | 2004-10-18 |
Biogen Inc
(BIIB)
|
PS Planned sale |
1,500
-3.6%
57.5086,250 USD |
1,500 -3.6% | 57.50 | 86,250 USD | |
2004-10-13 | 2004-10-11 |
Biogen Inc
(BIIB)
|
PS Planned sale |
1,000
-2.3%
60.0060,000 USD |
1,000 -2.3% | 60.00 | 60,000 USD | |
2004-10-13 | 2004-10-11 |
Biogen Inc
(BIIB)
|
PS Planned sale |
1,500
-3.4%
59.9589,925 USD |
1,500 -3.4% | 59.95 | 89,925 USD | |
2004-10-13 | 2004-10-11 |
Biogen Inc
(BIIB)
|
PS Planned sale |
1,325
-2.9%
60.3379,937 USD |
1,325 -2.9% | 60.33 | 79,937 USD | |
2004-10-13 | 2004-10-11 |
Biogen Inc
(BIIB)
|
PS Planned sale |
175
-100.0%
60.3310,558 USD |
175 -100.0% | 60.33 | 10,558 USD | |
2004-10-13 | 2004-10-11 |
Biogen Inc
(BIIB)
|
PS Planned sale |
1,500
-89.6%
60.1290,180 USD |
1,500 -89.6% | 60.12 | 90,180 USD | |
2004-10-05 | 2004-10-04 |
Biogen Inc
(BIIB)
|
PS Planned sale |
1,000
-37.4%
62.3862,380 USD |
1,000 -37.4% | 62.38 | 62,380 USD | |
2004-10-05 | 2004-10-04 |
Biogen Inc
(BIIB)
|
PS Planned sale |
1,500
-35.9%
62.7794,158 USD |
1,500 -35.9% | 62.77 | 94,158 USD | |
2004-10-05 | 2004-10-04 |
Biogen Inc
(BIIB)
|
PS Planned sale |
1,500
-26.4%
62.8594,268 USD |
1,500 -26.4% | 62.85 | 94,268 USD | |
2004-10-05 | 2004-10-04 |
Biogen Inc
(BIIB)
|
PS Planned sale |
1,500
-20.9%
62.4893,723 USD |
1,500 -20.9% | 62.48 | 93,723 USD | |
2004-07-27 | 2004-07-26 |
Biogen Inc
(BIIB)
|
PS Planned sale |
1,500
-2.6%
53.4480,157 USD |
1,500 -2.6% | 53.44 | 80,157 USD | |
2004-07-27 | 2004-07-26 |
Biogen Inc
(BIIB)
|
PS Planned sale |
1,500
-2.5%
53.3580,025 USD |
1,500 -2.5% | 53.35 | 80,025 USD | |
2004-07-27 | 2004-07-19 |
Biogen Inc
(BIIB)
|
PS Planned sale |
1,500
-2.6%
53.5180,259 USD |
1,500 -2.6% | 53.51 | 80,259 USD | |
2004-07-20 | 2004-07-19 |
Biogen Inc
(BIIB)
|
PS Planned sale |
1,500
-2.4%
57.9686,933 USD |
1,500 -2.4% | 57.96 | 86,933 USD | |
2004-07-20 | 2004-07-19 |
Biogen Inc
(BIIB)
|
PS Planned sale |
1,500
-2.4%
57.9086,849 USD |
1,500 -2.4% | 57.90 | 86,849 USD | |
2004-07-20 | 2004-07-19 |
Biogen Inc
(BIIB)
|
PS Planned sale |
1,500
-2.3%
57.9286,877 USD |
1,500 -2.3% | 57.92 | 86,877 USD | |
2004-07-15 | 2004-07-13 |
Biogen Inc
(BIIB)
|
PS Planned sale |
1,000
-1.5%
60.7060,700 USD |
1,000 -1.5% | 60.70 | 60,700 USD | |
2004-07-15 | 2004-07-13 |
Biogen Inc
(BIIB)
|
PS Planned sale |
1,500
-2.2%
60.5090,755 USD |
1,500 -2.2% | 60.50 | 90,755 USD | |
2004-07-15 | 2004-07-13 |
Biogen Inc
(BIIB)
|
PS Planned sale |
1,500
-2.2%
60.4890,723 USD |
1,500 -2.2% | 60.48 | 90,723 USD | |
2004-07-15 | 2004-07-13 |
Biogen Inc
(BIIB)
|
PS Planned sale |
1,500
-2.1%
60.6991,037 USD |
1,500 -2.1% | 60.69 | 91,037 USD | |
2004-07-09 | 2004-07-06 |
Biogen Inc
(BIIB)
|
PS Planned sale |
1,000
-1.4%
62.0762,070 USD |
1,000 -1.4% | 62.07 | 62,070 USD | |
2004-07-09 | 2004-07-06 |
Biogen Inc
(BIIB)
|
PS Planned sale |
1,500
-2.1%
61.9992,985 USD |
1,500 -2.1% | 61.99 | 92,985 USD | |
2004-07-09 | 2004-07-06 |
Biogen Inc
(BIIB)
|
PS Planned sale |
925
-1.3%
61.9857,335 USD |
925 -1.3% | 61.98 | 57,335 USD | |
2004-07-09 | 2004-07-06 |
Biogen Inc
(BIIB)
|
PS Planned sale |
575
-100.0%
61.9835,641 USD |
575 -100.0% | 61.98 | 35,641 USD | |
2004-07-09 | 2004-07-06 |
Biogen Inc
(BIIB)
|
PS Planned sale |
1,500
-72.3%
63.9795,959 USD |
1,500 -72.3% | 63.97 | 95,959 USD | |
2004-05-26 | 2004-05-24 |
Biogen Inc
(BIIB)
|
PS Planned sale |
1,000
-3.3%
61.3261,320 USD |
1,000 -3.3% | 61.32 | 61,320 USD | |
2004-05-26 | 2004-05-24 |
Biogen Inc
(BIIB)
|
PS Planned sale |
1,500
-4.7%
61.2991,932 USD |
1,500 -4.7% | 61.29 | 91,932 USD | |
2004-05-26 | 2004-05-24 |
Biogen Inc
(BIIB)
|
PS Planned sale |
1,500
-4.5%
61.2691,896 USD |
1,500 -4.5% | 61.26 | 91,896 USD | |
2004-05-26 | 2004-05-24 |
Biogen Inc
(BIIB)
|
PS Planned sale |
1,500
-4.3%
61.3792,051 USD |
1,500 -4.3% | 61.37 | 92,051 USD | |
2004-05-14 | 2004-05-14 |
PerkinElmer Inc
(PKI)
|
B Purchase |
5,000
+124.4%
18.3391,650 USD |
5,000 +124.4% | 18.33 | 91,650 USD |